The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-benzamido-4-methyl-N-phenylthiazole-5-carboxamide ID: ALA3104387
PubChem CID: 860667
Max Phase: Preclinical
Molecular Formula: C18H15N3O2S
Molecular Weight: 337.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(NC(=O)c2ccccc2)sc1C(=O)Nc1ccccc1
Standard InChI: InChI=1S/C18H15N3O2S/c1-12-15(17(23)20-14-10-6-3-7-11-14)24-18(19-12)21-16(22)13-8-4-2-5-9-13/h2-11H,1H3,(H,20,23)(H,19,21,22)
Standard InChI Key: VUPOVEVEJLSSRH-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
0.5434 -25.2338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5422 -26.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2503 -26.4623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9599 -26.0529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9571 -25.2302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2485 -24.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6633 -24.8190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3725 -25.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0787 -24.8136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3756 -26.0421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8258 -25.1420 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3703 -24.5327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9590 -23.8264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1604 -23.9995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1833 -24.6150 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5185 -25.3603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3315 -25.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0407 -26.0232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6622 -26.1885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4745 -26.2711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9532 -25.6077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6139 -24.8597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8026 -24.7807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5507 -23.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 9 2 0
12 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
14 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.40Molecular Weight (Monoisotopic): 337.0885AlogP: 3.96#Rotatable Bonds: 4Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.71CX Basic pKa: ┄CX LogP: 3.76CX LogD: 3.76Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.76Np Likeness Score: -1.95
References 1. Sun S, Zhang Z, Raina V, Pokrovskaia N, Hou D, Namdari R, Khakh K, Ratkay LG, McLaren DG, Mork M, Fu J, Ferreira S, Hubbard B, Winther MD, Dales N.. (2014) Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects., 24 (2): [PMID:24370012 ] [10.1016/j.bmcl.2013.12.035 ] 2. Sun S, Zhang Z, Kodumuru V, Pokrovskaia N, Fonarev J, Jia Q, Leung PY, Tran J, Ratkay LG, McLaren DG, Radomski C, Chowdhury S, Fu J, Hubbard B, Winther MD, Dales NA.. (2014) Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases., 24 (2): [PMID:24374272 ] [10.1016/j.bmcl.2013.12.036 ]